Rebolleda Gema, Muñoz-Negrete Francisco J, Benatar Jacobo, Corcostegui Juan, Alonso Nieves
Ophthalmology Department, Glaucoma Unit, Hospital Ramón y Cajal, University of Alcalá, Madrid, Spain.
Acta Ophthalmol Scand. 2005 Apr;83(2):201-5. doi: 10.1111/j.1600-0420.2005.00420.x.
To compare patient comfort and the efficacy of lidocaine 2% gel versus retrobulbar anaesthesia for Ahmed glaucoma implant surgery.
This prospective study included 32 eyes of 32 patients scheduled to undergo implantation of an Ahmed glaucoma drainage device for refractory glaucoma in one institution, randomized to receive either topical lidocaine 2% gel or retrobulbar anaesthesia. Sixteen eyes were randomized to each group. Patient assessment of pain was recorded during delivery of anaesthesia, during surgery and after surgery, using a visual analogue pain scale. The need for additional anaesthesia during tissue manipulation was recorded. Surgeon assessments of operative conditions, patient co-operation and intraoperative complications were also recorded.
The patients in the retrobulbar group reported significantly more discomfort during administration of the anaesthetic agent than the patients in the topical anaesthesia group (p = 0.000). There was no significant difference in patient-reported pain scores intraoperatively (p = 0.317) or postoperatively (p = 0.875). Surgeon assessment showed similar levels of patient co-operation in both groups (p = 0.615). The overall operating conditions were overwhelmingly positive in each group (p = 0.186). The mean duration of surgery was significantly longer in the topical group compared with the retrobulbar group (p = 0.049).
Lidocaine 2% gel is a safe alternative to retrobulbar anaesthesia for Ahmed drainage implant surgery and avoids the significantly greater pain associated with the administration of retrobulbar anaesthesia. It provides a reasonably safe and comfortable surgical environment and is well tolerated by patients.
比较2%利多卡因凝胶与球后麻醉用于艾哈迈德青光眼引流植入手术时患者的舒适度及疗效。
这项前瞻性研究纳入了在一家机构计划接受艾哈迈德青光眼引流装置植入术治疗难治性青光眼的32例患者的32只眼,随机分为两组,分别接受局部应用2%利多卡因凝胶或球后麻醉。每组16只眼。使用视觉模拟疼痛量表记录麻醉给药期间、手术期间及手术后患者的疼痛评估情况。记录组织操作过程中追加麻醉的需求。同时记录外科医生对手术条件、患者配合度及术中并发症的评估情况。
球后麻醉组患者在麻醉剂给药期间报告的不适感明显多于局部麻醉组患者(p = 0.000)。患者报告的术中疼痛评分(p = 0.317)及术后疼痛评分(p = 0.875)无显著差异。外科医生评估显示两组患者的配合程度相似(p = 0.615)。每组的总体手术条件均呈压倒性的积极评价(p = 0.186)。与球后麻醉组相比,局部麻醉组的平均手术时间明显更长(p = 0.049)。
对于艾哈迈德引流植入手术,2%利多卡因凝胶是球后麻醉的一种安全替代方法,可避免与球后麻醉给药相关的明显更剧烈疼痛。它提供了一个相当安全且舒适的手术环境,患者耐受性良好。